Skip to content
Search

Latest Stories

'Almost all double vaccinated people have antibodies'

Nearly 100 per cent of people tested positive for Covid-19 antibodies after their second dose of Pfizer or AstraZeneca vaccine, a joint study by Imperial College London and Ipsos MORI has revealed.

The report highlighted the importance of getting both doses for the best possible protection as restrictions are eased. The findings show vaccine uptake remained high in May.


Over 207,337 participants tested themselves at home using a finger prick test between 12 and 25 May 2021, tracking Covid-19 antibodies across England following either natural infection or vaccination.

More than 90 per cent of people aged over 65 tested positive for antibodies, rising to 95 per cent in those aged over 75 with 36 per cent of 18 to 24 year olds testing positive. At the time of the report, a quarter of respondents aged 18 to 24 said they had received one or 2 jabs compared to 99 per cent of those aged over 75.

Health secretary Sajid Javid said: "This is a testament to the very high level of protection the vaccine provides – with 46,000 hospitalisations prevented and 30,000 lives saved.

"I urge everyone to come forward for the vaccine, regardless of your race, religion or background. It could save your life and protect your loved ones, and getting the second jab will help us all return to doing the things we love."

Vaccines minister Nadhim Zahawi said: "Our vaccination programme is working and is severely weakening the link between cases, hospitalisations and deaths. We are continuing to make strong progress in boosting uptake for people living in deprived areas, as well as black and minority ethnic communities by working closely with faith and local leaders."

Professor Helen Ward, from Imperial College London, said: "Results of this very large study show the substantial impact of the vaccination programme on antibody positivity in adults. However, coverage of vaccines is uneven with people in some groups and areas less likely to have been vaccinated.

"It is concerning that people on low incomes, in deprived areas, some minority ethnic groups and in some public facing occupations such as hospitality, may remain relatively unprotected from future spread. We need to continue and intensify efforts to reach these groups with vaccination, and to ensure other protective measures are in place."

In total, 34,997,491 million people in the UK have now received both doses of vaccine, and the government remains on track to offer a first dose to all over 18 year olds by 19 July.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less